Delivery Order SPE2DB22D1106-SPE2DB25FFDW7
- Not listed
- The Defense Logistics Agency awarded a $3,622.98 delivery order to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 2.5-1% cream in 30-gram units, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger contract vehicle with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $1,741.30 to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 1%-1% cream in 30-gram units. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime...
- The Defense Logistics Agency awarded a $3,778.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 2.5-1% cream (28.4 grams) on August 27, 2025, with completion targeted for August 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was not set-aside and was competitively awarded....
- The Defense Logistics Agency awarded a $1,962.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 1%-1% Cream, 30 gram units, with an ultimate completion date of July 17, 2025. This is a non-set-aside contract, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement needs, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,464.46 to AmerisourceBergen Drug Corp for Hydrocortisone-Pramoxine 2.5-1% cream in 30-gram units. This firm fixed price delivery order, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award was competitively awarded with no set-aside designation and will be performed at the contractor's facility in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a pharmaceutical product - Hydrocort-Pramoxine 2.5-1% Cream 30GM. The $2,002.93 contract has an ultimate completion date of April 12, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp to deliver a comprehensive range of...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Hydrocort-Pramoxine 1%-1% Cream, 30 grams, with a ceiling value of $1,724.46 and a completion date of April 15, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by...
- The Defense Logistics Agency awarded a delivery order valued at $1,483.28 to AmerisourceBergen Drug Corp for the supply of Hydrocortisone 1% Cream in 28-gram units. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,622.91 to AmerisourceBergen Drug Corp for the supply of 4567330281 - Hydrocortisone 1% Cream 28.4GM. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, which runs...
- This is a $1,434.24 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Hydrocortisone-Pramoxine 2.5-1% cream. The order has a completion date of September 18, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a wide range of medical commodities to support military...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFDW7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,545.65 to AmerisourceBergen Drug Corp for the supply of Hydrocort-Pramoxine 1%-1% cream in 30-gram quantities. This contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive pharmaceutical prime vendor vehicle enables AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs globally. The company's federal contract portfolio demonstrates its established capability to meet defense medical procurement requirements across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/18/25 |